Corrigendum to: Zaninotto M, Plebani M. Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals. Clin Chem Lab Med 2020;58(3):1005–1005. https://doi.org/10.1515/cclm-2019-0898
Unfortunately, the article contains two typos both in the Abstract and in the section “Frequency and type of interferences”: in two sentences it reads “… that are not undetectable before analysis …”, however, “not” is mistakenly included in the sentences.
The correct sentences should read:
The first (type 1) is represented by lipemia, hemolysis and icterus, and the second (type 2), by unusual constituents that are undetectable before analysis, and may affect the matrix of serum/plasma of individual subjects.
The first (type 1), easy to detect, is represented by lipemia, hemolysis and icterus, and the second (type 2), by unusual constituents that are undetectable before analysis, and may affect the matrix of serum/plasma of individual subjects.
© 2021 Martina Zaninotto and Mario Plebani, published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
